Pharma Mar SA
MAD:PHM
Wall Street
Price Targets
PHM Price Targets Summary
Pharma Mar SA
According to Wall Street analysts, the average 1-year price target for
PHM
is 99.84 EUR
with a low forecast of 58.48 EUR and a high forecast of 126 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PHM's stock price target?
Price Target
99.84
EUR
According to Wall Street analysts, the average 1-year price target for
PHM
is 99.84 EUR
with a low forecast of 58.48 EUR and a high forecast of 126 EUR.
What is Pharma Mar SA's Revenue forecast?
Projected CAGR
23%
For the last 13 years the
compound annual growth rate for
Pharma Mar SA's revenue is
0%.
The projected
CAGR
for the next 4 years is
23%.
What is Pharma Mar SA's Operating Income forecast?
Projected CAGR
140%
For the last 13 years the
compound annual growth rate for
Pharma Mar SA's operating income is
-10%.
The projected
CAGR
for the next 4 years is
140%.
What is Pharma Mar SA's Net Income forecast?
Projected CAGR
63%
For the last 13 years the
compound annual growth rate for
Pharma Mar SA's net income is
14%.
The projected
CAGR
for the next 4 years is
63%.
